Only 66 of the 168 innovative medicinal treatments approved by EU authorities from 2021 to 2024 were available in Cyprus, a survey has shown.
Carried out by the European Federation of Pharmaceutical Industries and Associations (Efpia), the survey showed Cyprus lagging behind both in terms of the number of available medicinal products and in terms of the time needed for the products to come to market.
According to the Patients
